Sponsor or institution

Clinical trials and research at Tianjin First Central Hospital

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Tianjin First Central Hospital that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
NK Cells Plus Immunotherapy for Extensive-Stage Small Cell Lung Cancer Maintenance Phase 2 Tianjin, Tianjin Municipality Recruiting Aug 12, 2026
YH02 injection for intratumor therapy in advanced solid tumors Phase 2 Tianjin Recruiting Jul 13, 2026
Liposomal Bupivacaine TAP Block Plus Pain Control to Help Gut Recovery After Major Abdominal Surgery — Tianjin, Tianjin Municipality Recruiting Jun 16, 2026
Liposomal Bupivacaine vs Ropivacaine for TAP Block in Laparoscopic Gallbladder Surgery — Tianjin, Tianjin Municipality Recruiting May 11, 2026

All recruiting trials (4)

Quick answers

How many clinical trials run by Tianjin First Central Hospital are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.